about
Membranotropic Cell Penetrating Peptides: The Outstanding JourneygH625: a milestone in understanding the many roles of membranotropic peptidesSilver nanoparticles as potential antiviral agentsStructure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic systemSilver nanoparticles as potential antibacterial agentsElucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimersBiophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus.Microbe-host interactions: structure and role of Gram-negative bacterial porinsPeptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in ratsThe identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial moleculesDendrimers functionalized with membrane-interacting peptides for viral inhibition.Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfishPeptide inhibitors against herpes simplex virus infections.Exploitation of viral properties for intracellular delivery.Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity.Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H.Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3.Peptide-lipid interactions: experiments and applications.Fusion of raft-like lipid bilayers operated by a membranotropic domain of the HSV-type I glycoprotein gH occurs through a cholesterol-dependent mechanism.Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity.Structural insights into and activity analysis of the antimicrobial peptide myxinidin.Conformational modifications of gB from herpes simplex virus type 1 analyzed by synthetic peptides.Analysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein H.Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process.A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots.Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery.Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.Lipid composition modulates the interaction of peptides deriving from herpes simplex virus type I glycoproteins B and H with biomembranes.Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B.Fusogenic domains in herpes simplex virus type 1 glycoprotein H.Integrated analysis of the ecotoxicological and genotoxic effects of the antimicrobial peptide melittin on Daphnia magna and Pseudokirchneriella subcapitata.Shuttle-mediated nanoparticle delivery to the blood-brain barrier.Evidence for IL-6 promoter nuclear activation in U937 cells stimulated with Salmonella enterica serovar Typhimurium porins.Toxicity Effects of Functionalized Quantum Dots, Gold and Polystyrene Nanoparticles on Target Aquatic Biological Models: A Review.Enforcing the positive charge of N-termini enhances membrane interaction and antitumor activity of bovine seminal ribonuclease
P50
Q26778015-AED3B610-2B6D-49BE-9734-03867F17D406Q26864389-5124B974-AAE3-4F3E-81B3-311EAD6790C0Q26998834-1C1CF485-510A-4B99-9702-DDB729E19297Q27677898-B268EA5D-F7D7-4422-B377-DB3C59B429C8Q28082472-D6F75ABA-5406-4C47-9AE9-82525DF957BCQ28545166-4183CC10-C803-4CDC-A9C0-6D91219FD457Q34182329-AEF92BD3-FADD-48D2-91EA-0CFC8BC27048Q34321941-BC34355C-6D8D-4898-823E-C2D1B2CD0A9AQ35189757-EC05C7EB-D976-4B7A-ADAB-3DFBECF8CA35Q36024399-B193659E-CB89-40E4-AABA-5B39A4DFA9B6Q36617825-53FBEA18-4420-4093-9920-D4152DC9175AQ37263518-3D7C489D-F896-46F8-9362-8AEE5338B0CEQ38079780-8E0B6D07-BE1D-40F1-A25D-F73FA802C858Q38216947-89AFABF6-9D5F-477E-BD34-B93B86A4168BQ38561362-D0AC280B-3303-4715-9937-98D7195D1A94Q38884957-5A53E616-5D1A-4F9F-8538-DAB42D6E4CFCQ39447286-2196F562-F633-4E4B-A94D-08CB6618FD89Q39996592-E9BAE5EE-83DF-4D96-9489-94596009F1B2Q40007322-2F5341AD-10D2-4BD5-A6A8-78E51A73C3CDQ40800166-EFC2BEFC-4237-425F-9000-C8EEB03E508CQ41813888-21E43686-1B3A-4818-ACFF-5A95CFDE96DFQ42017138-D218EBDE-9D3E-4E46-91A7-80C476B33ED4Q42157805-827F9557-91AD-40E6-8DDA-900CC428BDF0Q42181597-5235093F-8590-49A7-9C74-E58E2D73FC41Q42209245-61316C6C-475E-4D1A-AD27-D182418B92C8Q42259706-503F7CE0-3A08-4BB5-94CA-2C1D2C267380Q42736704-80E051D1-C146-48E2-BEF5-65DDB32E633CQ43189821-EF935622-E890-4182-9134-B851CC45FFC6Q43996765-7D12309F-F765-4E12-9767-908B9E30AE71Q45097356-A0A8B2FE-F822-44E0-9155-D6D4C7E93191Q45362938-997F4DA7-0C7A-466A-8720-D88B81DF8D66Q45364614-30BC14EF-605A-4777-AFB1-87255AFDEF58Q45394231-09D79CB3-CAF3-488B-8081-3A87968EBC3DQ45417927-1E2A2D36-8C4D-49EB-9E0A-EB9F21ED2543Q45453152-5D9F9342-847D-4F6E-9A5A-E70A91F07557Q46742079-ADA19BD4-D7CB-4BFF-AA20-861BEA752A20Q48304144-309D38AB-4AC7-4646-9E8A-CEDAD3675A98Q50052652-EDC6833D-FB10-48EA-A089-C6C63ABA76A9Q50247076-FEC52F6B-49FE-4EDA-A456-ECC1D58089ABQ57631736-7EE087F1-3D1D-4B56-9E2A-01A71207BA87
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annarita Falanga
@ast
Annarita Falanga
@en
Annarita Falanga
@es
Annarita Falanga
@nl
type
label
Annarita Falanga
@ast
Annarita Falanga
@en
Annarita Falanga
@es
Annarita Falanga
@nl
prefLabel
Annarita Falanga
@ast
Annarita Falanga
@en
Annarita Falanga
@es
Annarita Falanga
@nl
P106
P1153
8676567000
P21
P31
P496
0000-0001-6538-8585
P569
2000-01-01T00:00:00Z